A New Mechanism Involving ERK Contributes to Rosiglitazone Inhibition of Tumor Necrosis Factor-α and Interferon-γ Inflammatory Effects in Human Endothelial Cells - Concepedia

Concepedia

Publication | Closed Access

A New Mechanism Involving ERK Contributes to Rosiglitazone Inhibition of Tumor Necrosis Factor-α and Interferon-γ Inflammatory Effects in Human Endothelial Cells

71

Citations

30

References

2008

Year

Adriana Lombardi, Giulia Cantini, Elisabetta Piscitelli, Stefania Gelmini, Michela Francalanci, Tommaso Mello, E. Ceni, Gabriele Varano, Gianni Forti, Mario Rotondi,

Arteriosclerosis Thrombosis and Vascular Biology

Abstract

Our findings shed new light on the mechanisms underlying the inflammatory response of microvascular endothelium and on the possible therapeutic use of RGZ in vasculopathies involving Th1-responses.

References

	Year	Citations

Page 1